AvePoint, Inc.·4

Mar 18, 8:49 PM ET

Brown Brian Michael 4

4 · AvePoint, Inc. · Filed Mar 18, 2026

Research Summary

AI-generated summary of this filing

Updated

AvePoint (AVPT) CLO Brian Brown Receives 190K RSUs, Exercises Options

What Happened

  • Brian Michael Brown, Chief Legal Officer and Director of AvePoint (AVPT), received two awards on March 16, 2026 totaling 190,115 restricted stock units (RSUs) (142,586 and 47,529 shares) at $0 per share (non‑cash compensation).
  • On March 17, 2026 he reported exercise/conversion of derivative instruments for 1,803 shares (acquired) and a corresponding derivative disposition of 1,803 shares, both reported at $0. These entries are recorded as an award (A) and exercise/conversion of a derivative (M), not open‑market purchases or standard cash sales.

Key Details

  • Transaction dates: RSU grants on 2026-03-16; exercise/conversion and derivative disposition on 2026-03-17. Filing date: 2026-03-18 (report period 2026-03-16).
  • Prices / reported values: all entries reported at $0 per share (typical for RSU grants and certain option conversions/net settlements).
  • Shares reported granted: 142,586 RSUs + 47,529 RSUs = 190,115 RSUs. Derivative shares: 1,803 exercised/converted (and 1,803 derivative disposition) reported.
  • Holdings after transaction: the filing references aggregate holdings (vested and unvested RSUs and non‑RSU common stock) per footnote but does not state a single consolidated post‑transaction total in the provided summary.
  • Relevant footnotes:
    • F1: RSUs represent contingent rights to receive one share upon vesting.
    • F2: Vesting schedule — 25% vests March 15, 2027, remaining vests quarterly thereafter, subject to continued service.
    • F4: Some awards are performance‑based RSUs (PRSUs) tied to ARR growth (70%) and FY2028 GAAP profitability (30%) with payouts possible from 50%–200% of target, vesting upon committee certification.
    • F5: Options reported relate to prior grants under the 2016 equity plan that were exercised.
  • Timeliness: Filing was made 2 days after the primary grant date, consistent with timely reporting.

Context for Retail Investors

  • RSU grants are compensation, not direct purchases by the insider; they indicate company compensation decisions rather than an immediate cash investment by the insider.
  • Exercise/conversion entries (M) indicate the insider converted derivative rights into shares; the same‑day derivative disposition was reported but the filing does not specify whether that was a sale to cover taxes, a net settlement, or another administrative disposition.
  • Purchases by insiders typically carry more direct signaling value than grants; here the primary activity is compensation (RSUs) plus a small derivative conversion.

Insider Transaction Report

Form 4
Period: 2026-03-16
Brown Brian Michael
DirectorChief Legal Officer
Transactions
  • Award

    Common Stock

    [F1][F2][F3]
    2026-03-16+142,586772,392 total
  • Award

    Common Stock

    [F1][F4][F3]
    2026-03-16+47,529819,921 total
  • Exercise/Conversion

    Common Stock

    [F1][F3]
    2026-03-17+1,803821,724 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F5]
    2026-03-171,8032,263,299 total
    Exercise: $1.34From: 2020-07-01Exp: 2026-07-01Common Stock (1,803 underlying)
Footnotes (5)
  • [F1]This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  • [F2]25% of the RSUs will vest on March 15, 2027, and the remaining RSUs will vest in 12 quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. Each vesting event will occur on the 15th day of the applicable vesting month, or, if not a business day, the next business day.
  • [F3]Includes non-RSU common stock as well as aggregate vested and unvested RSUs held by the Reporting Person subject to the vesting schedules previously reported on Table I of Form 4s filed with the Securities and Exchange Commission on September 3, 2021, March 22, 2022, March 23, 2023, March 7, 2024, and March 18, 2025.
  • [F4]Represents performance-based RSUs ("PRSUs") based upon two metrics: Annual recurring revenue compounded annual growth rate for the years 2026-2028 (70% weighted) and FY 2028 GAAP profitability (30% weighted). Actual payouts may represent 50% to 200% of granted value. These PRSUs will fully vest upon certification of the actual payouts by the Issuer's Compensation Committee after the performance period ends.
  • [F5]This security represents options to purchase the Issuer's common stock granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan that have been exercised.
Signature
/s/ Brian Michael Brown|2026-03-18

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4